{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:40:31Z","timestamp":1791268831168,"version":"4.1.0"},"reference-count":60,"publisher":"Oxford University Press (OUP)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nephrol. Dial. Transplant."],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1093\/ndt\/gfu368","type":"journal-article","created":{"date-parts":[[2014,12,6]],"date-time":"2014-12-06T05:56:48Z","timestamp":1417845408000},"page":"1449-1455","source":"Crossref","is-referenced-by-count":75,"title":["Inhibition of the VEGF signalling pathway and glomerular disorders"],"prefix":"10.1093","volume":"30","author":[{"given":"Mario","family":"Ollero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djillali","family":"Sahali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,12,5]]},"reference":[{"key":"2015082613275649000_30.9.1449.1","doi-asserted-by":"publisher","DOI":"10.3816\/CCC.2004.s.010"},{"key":"2015082613275649000_30.9.1449.2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-01222-8_1"},{"key":"2015082613275649000_30.9.1449.3","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(89)92678-8"},{"key":"2015082613275649000_30.9.1449.4","doi-asserted-by":"publisher","DOI":"10.1038\/359843a0"},{"key":"2015082613275649000_30.9.1449.5","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0b013e32835004ac"},{"key":"2015082613275649000_30.9.1449.6","doi-asserted-by":"crossref","unstructured":"Neufeld G Cohen T Gengrinovitch S Vascular endothelial growth factor (VEGF) and its receptors. Faseb J 1999; 13: 9\u201322","DOI":"10.1096\/fasebj.13.1.9"},{"key":"2015082613275649000_30.9.1449.7","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2006.050834"},{"key":"2015082613275649000_30.9.1449.8","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2009.130"},{"key":"2015082613275649000_30.9.1449.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0706596"},{"key":"2015082613275649000_30.9.1449.10","doi-asserted-by":"crossref","unstructured":"Homsi J Daud AI . Spectrum of activity and mechanism of action of VEGF\/PDGF inhibitors. Cancer Control 2007; 14: 285\u2013294","DOI":"10.1177\/107327480701400312"},{"key":"2015082613275649000_30.9.1449.11","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-013-2696-0"},{"key":"2015082613275649000_30.9.1449.12","unstructured":"London CA Hannah AL Zadovoskaya R Phase I dose-escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies. Clin Cancer Res 2003; 9: 2755\u20132768"},{"key":"2015082613275649000_30.9.1449.13","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-2-33"},{"key":"2015082613275649000_30.9.1449.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2008.08.010"},{"key":"2015082613275649000_30.9.1449.15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0707330"},{"key":"2015082613275649000_30.9.1449.16","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2006.11.039"},{"key":"2015082613275649000_30.9.1449.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2009.11.001"},{"key":"2015082613275649000_30.9.1449.18","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2013.344"},{"key":"2015082613275649000_30.9.1449.19","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfn657"},{"key":"2015082613275649000_30.9.1449.20","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2007.04.025"},{"key":"2015082613275649000_30.9.1449.21","doi-asserted-by":"publisher","DOI":"10.1038\/ncpneph0476"},{"key":"2015082613275649000_30.9.1449.22","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-011-0543-9"},{"key":"2015082613275649000_30.9.1449.23","doi-asserted-by":"crossref","unstructured":"Okuno Y Kume H Hosoda C Development of nephrotic syndrome after administration of sorafenib in a case of metastatic renal cell carcinoma. Case Rep Med 2011; 2011: 710216","DOI":"10.1155\/2011\/710216"},{"key":"2015082613275649000_30.9.1449.24","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2013.01.022"},{"key":"2015082613275649000_30.9.1449.25","doi-asserted-by":"crossref","unstructured":"Quintyne KI Neenan T Casserly L Uncommon side effect with a commonly used targeted agent: sunitinib-induced nephrotic syndrome in a patient with metastatic renal cell carcinoma. BMJ Case Rep 2014; 2014","DOI":"10.1136\/bcr-2013-201183"},{"key":"2015082613275649000_30.9.1449.26","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(07)70037-2"},{"key":"2015082613275649000_30.9.1449.27","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C300012200"},{"key":"2015082613275649000_30.9.1449.28","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2000678"},{"key":"2015082613275649000_30.9.1449.29","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-03-144691"},{"key":"2015082613275649000_30.9.1449.30","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200317189"},{"key":"2015082613275649000_30.9.1449.31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031884"},{"key":"2015082613275649000_30.9.1449.32","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2590"},{"key":"2015082613275649000_30.9.1449.33","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00137.2009"},{"key":"2015082613275649000_30.9.1449.34","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.107.150474"},{"key":"2015082613275649000_30.9.1449.35","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.107.158295"},{"key":"2015082613275649000_30.9.1449.36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055027"},{"key":"2015082613275649000_30.9.1449.37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00424.x"},{"key":"2015082613275649000_30.9.1449.38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021491"},{"key":"2015082613275649000_30.9.1449.39","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5000439"},{"key":"2015082613275649000_30.9.1449.40","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00276.2002"},{"key":"2015082613275649000_30.9.1449.41","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00448.2005"},{"key":"2015082613275649000_30.9.1449.42","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.64"},{"key":"2015082613275649000_30.9.1449.43","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2010030295"},{"key":"2015082613275649000_30.9.1449.44","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.241620"},{"key":"2015082613275649000_30.9.1449.45","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.15.10002"},{"key":"2015082613275649000_30.9.1449.46","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M603928200"},{"key":"2015082613275649000_30.9.1449.47","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-004-7960-2"},{"key":"2015082613275649000_30.9.1449.48","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00431.2005"},{"key":"2015082613275649000_30.9.1449.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2012.11.017"},{"key":"2015082613275649000_30.9.1449.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2009.05.019"},{"key":"2015082613275649000_30.9.1449.51","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.06106-11"},{"key":"2015082613275649000_30.9.1449.52","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M608519200"},{"key":"2015082613275649000_30.9.1449.53","doi-asserted-by":"publisher","DOI":"10.1126\/science.286.5438.312"},{"key":"2015082613275649000_30.9.1449.54","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005080835"},{"key":"2015082613275649000_30.9.1449.55","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00712.x"},{"key":"2015082613275649000_30.9.1449.56","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006010064"},{"key":"2015082613275649000_30.9.1449.57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0096117"},{"key":"2015082613275649000_30.9.1449.58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094540"},{"key":"2015082613275649000_30.9.1449.59","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2014.29.1.40"},{"key":"2015082613275649000_30.9.1449.60","doi-asserted-by":"crossref","unstructured":"Hsu FT Liu YC Chiang IT Sorafenib increases efficacy of vorinostat against human hepatocellular carcinoma through transduction inhibition of vorinostat-induced ERK\/NF-kappaB signaling. Int J Oncol 2014; 45: 177\u2013188","DOI":"10.3892\/ijo.2014.2423"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/30\/9\/1449\/7638110\/gfu368.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T05:48:32Z","timestamp":1566107312000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article-lookup\/doi\/10.1093\/ndt\/gfu368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,5]]},"references-count":60,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2015,8,26]]},"published-print":{"date-parts":[[2015,9]]}},"alternative-id":["10.1093\/ndt\/gfu368"],"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfu368","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,5]]}}}